Brief: Ovid Therapeutics Expands Scientific Advisory Board
23/07/2024 13:21
July 23 (Reuters) - Ovid Therapeutics Inc OVID.O :
* OVID THERAPEUTICS EXPANDS SCIENTIFIC ADVISORY BOARD WITH
APPOINTMENTS OF LEADING NEUROLOGISTS, NEUROSCIENTISTS AND
EPILEPTOLOGISTS
* OVID THERAPEUTICS INC - ANTICIPATES MOVING ITS PIPELINE
FORWARD
WITH MULTIPLE MILESTONES EXPECTED IN SECOND HALF OF 2024
Source text for Eikon: ID:nGNX5qxx5n
Further company coverage: OVID.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ovid Therapeutics
See all newsOvid Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Ovid Therapeutics Q2 revenue beats estimates
Brief: Ovid Therapeutics Q2 EPS USD -0.08
Ovid Therapeutics Inc. expected to post a loss of 11 cents a share - Earnings Preview
Brief: Ovid Therapeutics Appoints Leading Physician-Scientist And Biotech Innovator Anna Greka, M.D., Ph.D., To Board Of Directors